Clinical Trials · NCT04428008
Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- William B. Ershler, MD
- Enrollment
- 189
- Start date
- Jan 2021
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants With COVID-19 Infection